AVSE:NYE-Avantis Responsible Emerging Markets Equity ETF (USD)

ETF | Others |

Last Closing

USD 48.7696

Change

+0.15 (+0.31)%

Market Cap

USD 0.07B

Volume

2.59K

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-04-24 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
SOJE SOJE

N/A

USD 65.72B
JEPI JPMorgan Equity Premium Income..

N/A

USD 32.43B
DTB DTB

N/A

USD 26.58B
DFAC Dimensional U.S. Core Equity 2..

N/A

USD 26.00B
GBTC Grayscale Bitcoin Trust (BTC)

N/A

USD 23.75B
JPST JPMorgan Ultra-Short Income ET..

N/A

USD 22.73B
SGOV iShares® 0-3 Month Treasury B..

N/A

USD 19.79B
AVUV Avantis® U.S. Small Cap Value..

N/A

USD 10.49B
DFUV Dimensional US Marketwide Valu..

N/A

USD 10.15B
DFAT Dimensional U.S. Targeted Valu..

N/A

USD 9.40B

ETFs Containing AVSE

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 1.70% 51% F 54% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 1.70% 44% F 47% F
Trailing 12 Months  
Capital Gain 11.42% 57% F 60% D-
Dividend Return 3.50% 59% D- 52% F
Total Return 14.92% 58% F 59% D-
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 3.07% 70% C- 53% F
Dividend Return 3.64% 70% C- 46% F
Total Return 0.57% 31% F 13% F
Risk Return Profile  
Volatility (Standard Deviation) 6.24% 70% C- 90% A-
Risk Adjusted Return 58.40% 83% B 83% B
Market Capitalization 0.07B 57% F 21% F

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:
Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.